The BRAF V600E Mutation Is a Predictor of the Effect of Radioiodine Therapy in Papillary Thyroid Cancer

Journal of Cancer - Australia
doi 10.7150/jca.33105
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2010English

Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib

Clinical Cancer Research
Cancer ResearchOncology
2014English

Radioiodine Therapy of Papillary Thyroid Cancer, Complicated by a Radial Myelitis. Clinical Case

The Russian Archives of Internal Medicine
2018English

Targeted Treatment of Papillary Craniopharyngiomas Harboring BRAF V600E Mutations

Cancer
Cancer ResearchOncology
2019English

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients With Acromegaly

PLoS ONE
Multidisciplinary
2014English

Newly Diagnosed Papillary Craniopharyngioma With BRAF V600E Mutation Treated With Single-Agent Selective BRAF Inhibitor Dabrafenib: A Case Report

Oncotarget
Oncology
2019English

Radiomics Study of Thyroid Ultrasound for Predicting BRAF Mutation in Papillary Thyroid Carcinoma: Preliminary Results

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2020English

Immunohistochemistry With Anti-Braf V600E (VE1) Mouse Monoclonal Antibody Is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases With and Without KRAS Mutation and Literature Review

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2017English

Is Radioiodine Administration in Patients With Papillary Thyroid Multifocal Microcarcinoma Unnecessary?

Endocrinology, Diabetes and Metabolism Case Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy